Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer Targeted Therapy market report explains the definition, types, applications, major countries, and major players of the Cancer Targeted Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Genetech
ImmunoGen
Dendreon Corporation
Peregrine Pharmaceuticals
Sanofi
Advaxis
Johnson & Johnson
GalaxoSmithKline
Eli Lily
NewLink Genetics
Bind Therapeutics
Celldex Therapeutics
Inovio Pharmaceuticals
Bristol Mayer Squibb
Novartis
Galena Biopharma
Merck
Roche
Seattle Genetics
Northwest Biotherapeutics
Teva
Boehringer Ingelheim
NeoStem Oncology
Pfizer
ImmunoCellular Therapeutics
By Type:
Tumor Antigens As Targets of Antibodies
Development of Antibodies for Clinical Purposes
Complement Dependent Cytotoxicity (CDC)
Signal Transduction Changes
By End-User:
Hospital
Clinic
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Cancer Targeted Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Cancer Targeted Therapy Outlook to 2028- Original Forecasts
-
2.2 Cancer Targeted Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Cancer Targeted Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Cancer Targeted Therapy Market- Recent Developments
-
6.1 Cancer Targeted Therapy Market News and Developments
-
6.2 Cancer Targeted Therapy Market Deals Landscape
7 Cancer Targeted Therapy Raw Materials and Cost Structure Analysis
-
7.1 Cancer Targeted Therapy Key Raw Materials
-
7.2 Cancer Targeted Therapy Price Trend of Key Raw Materials
-
7.3 Cancer Targeted Therapy Key Suppliers of Raw Materials
-
7.4 Cancer Targeted Therapy Market Concentration Rate of Raw Materials
-
7.5 Cancer Targeted Therapy Cost Structure Analysis
-
7.5.1 Cancer Targeted Therapy Raw Materials Analysis
-
7.5.2 Cancer Targeted Therapy Labor Cost Analysis
-
7.5.3 Cancer Targeted Therapy Manufacturing Expenses Analysis
8 Global Cancer Targeted Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Cancer Targeted Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Cancer Targeted Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Cancer Targeted Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Targeted Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tumor Antigens As Targets of Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Development of Antibodies for Clinical Purposes Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Complement Dependent Cytotoxicity (CDC) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Signal Transduction Changes Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Targeted Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Cancer Targeted Therapy Market Analysis and Outlook till 2022
-
10.1 Global Cancer Targeted Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Cancer Targeted Therapy Consumption (2017-2022)
-
10.2.2 Canada Cancer Targeted Therapy Consumption (2017-2022)
-
10.2.3 Mexico Cancer Targeted Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.2 UK Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.3 Spain Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.4 Belgium Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.5 France Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.6 Italy Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.7 Denmark Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.8 Finland Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.9 Norway Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.10 Sweden Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.11 Poland Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.12 Russia Cancer Targeted Therapy Consumption (2017-2022)
-
10.3.13 Turkey Cancer Targeted Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.2 Japan Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.3 India Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.4 South Korea Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.8 Thailand Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.9 Singapore Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.11 Philippines Cancer Targeted Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Cancer Targeted Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.2 Colombia Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.3 Chile Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.4 Argentina Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.6 Peru Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Cancer Targeted Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Cancer Targeted Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Cancer Targeted Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Cancer Targeted Therapy Consumption (2017-2022)
-
10.6.3 Oman Cancer Targeted Therapy Consumption (2017-2022)
-
10.6.4 Qatar Cancer Targeted Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Cancer Targeted Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Cancer Targeted Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Cancer Targeted Therapy Consumption (2017-2022)
-
10.7.2 South Africa Cancer Targeted Therapy Consumption (2017-2022)
-
10.7.3 Egypt Cancer Targeted Therapy Consumption (2017-2022)
-
10.7.4 Algeria Cancer Targeted Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Cancer Targeted Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Cancer Targeted Therapy Consumption (2017-2022)
11 Global Cancer Targeted Therapy Competitive Analysis
-
11.1 Genetech
-
11.1.1 Genetech Company Details
-
11.1.2 Genetech Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Genetech Cancer Targeted Therapy Main Business and Markets Served
-
11.1.4 Genetech Cancer Targeted Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 ImmunoGen
-
11.2.1 ImmunoGen Company Details
-
11.2.2 ImmunoGen Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 ImmunoGen Cancer Targeted Therapy Main Business and Markets Served
-
11.2.4 ImmunoGen Cancer Targeted Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Dendreon Corporation
-
11.3.1 Dendreon Corporation Company Details
-
11.3.2 Dendreon Corporation Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Dendreon Corporation Cancer Targeted Therapy Main Business and Markets Served
-
11.3.4 Dendreon Corporation Cancer Targeted Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Peregrine Pharmaceuticals
-
11.4.1 Peregrine Pharmaceuticals Company Details
-
11.4.2 Peregrine Pharmaceuticals Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Peregrine Pharmaceuticals Cancer Targeted Therapy Main Business and Markets Served
-
11.4.4 Peregrine Pharmaceuticals Cancer Targeted Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sanofi
-
11.5.1 Sanofi Company Details
-
11.5.2 Sanofi Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sanofi Cancer Targeted Therapy Main Business and Markets Served
-
11.5.4 Sanofi Cancer Targeted Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Advaxis
-
11.6.1 Advaxis Company Details
-
11.6.2 Advaxis Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Advaxis Cancer Targeted Therapy Main Business and Markets Served
-
11.6.4 Advaxis Cancer Targeted Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Johnson & Johnson
-
11.7.1 Johnson & Johnson Company Details
-
11.7.2 Johnson & Johnson Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Johnson & Johnson Cancer Targeted Therapy Main Business and Markets Served
-
11.7.4 Johnson & Johnson Cancer Targeted Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GalaxoSmithKline
-
11.8.1 GalaxoSmithKline Company Details
-
11.8.2 GalaxoSmithKline Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GalaxoSmithKline Cancer Targeted Therapy Main Business and Markets Served
-
11.8.4 GalaxoSmithKline Cancer Targeted Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Eli Lily
-
11.9.1 Eli Lily Company Details
-
11.9.2 Eli Lily Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Eli Lily Cancer Targeted Therapy Main Business and Markets Served
-
11.9.4 Eli Lily Cancer Targeted Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 NewLink Genetics
-
11.10.1 NewLink Genetics Company Details
-
11.10.2 NewLink Genetics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 NewLink Genetics Cancer Targeted Therapy Main Business and Markets Served
-
11.10.4 NewLink Genetics Cancer Targeted Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Bind Therapeutics
-
11.11.1 Bind Therapeutics Company Details
-
11.11.2 Bind Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Bind Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
11.11.4 Bind Therapeutics Cancer Targeted Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Celldex Therapeutics
-
11.12.1 Celldex Therapeutics Company Details
-
11.12.2 Celldex Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Celldex Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
11.12.4 Celldex Therapeutics Cancer Targeted Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Inovio Pharmaceuticals
-
11.13.1 Inovio Pharmaceuticals Company Details
-
11.13.2 Inovio Pharmaceuticals Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Inovio Pharmaceuticals Cancer Targeted Therapy Main Business and Markets Served
-
11.13.4 Inovio Pharmaceuticals Cancer Targeted Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bristol Mayer Squibb
-
11.14.1 Bristol Mayer Squibb Company Details
-
11.14.2 Bristol Mayer Squibb Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bristol Mayer Squibb Cancer Targeted Therapy Main Business and Markets Served
-
11.14.4 Bristol Mayer Squibb Cancer Targeted Therapy Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Novartis
-
11.15.1 Novartis Company Details
-
11.15.2 Novartis Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Novartis Cancer Targeted Therapy Main Business and Markets Served
-
11.15.4 Novartis Cancer Targeted Therapy Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Galena Biopharma
-
11.16.1 Galena Biopharma Company Details
-
11.16.2 Galena Biopharma Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Galena Biopharma Cancer Targeted Therapy Main Business and Markets Served
-
11.16.4 Galena Biopharma Cancer Targeted Therapy Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Merck
-
11.17.1 Merck Company Details
-
11.17.2 Merck Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Merck Cancer Targeted Therapy Main Business and Markets Served
-
11.17.4 Merck Cancer Targeted Therapy Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Roche
-
11.18.1 Roche Company Details
-
11.18.2 Roche Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Roche Cancer Targeted Therapy Main Business and Markets Served
-
11.18.4 Roche Cancer Targeted Therapy Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Seattle Genetics
-
11.19.1 Seattle Genetics Company Details
-
11.19.2 Seattle Genetics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Seattle Genetics Cancer Targeted Therapy Main Business and Markets Served
-
11.19.4 Seattle Genetics Cancer Targeted Therapy Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Northwest Biotherapeutics
-
11.20.1 Northwest Biotherapeutics Company Details
-
11.20.2 Northwest Biotherapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Northwest Biotherapeutics Cancer Targeted Therapy Main Business and Markets Served
-
11.20.4 Northwest Biotherapeutics Cancer Targeted Therapy Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Teva
-
11.21.1 Teva Company Details
-
11.21.2 Teva Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Teva Cancer Targeted Therapy Main Business and Markets Served
-
11.21.4 Teva Cancer Targeted Therapy Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Boehringer Ingelheim
-
11.22.1 Boehringer Ingelheim Company Details
-
11.22.2 Boehringer Ingelheim Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Boehringer Ingelheim Cancer Targeted Therapy Main Business and Markets Served
-
11.22.4 Boehringer Ingelheim Cancer Targeted Therapy Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 NeoStem Oncology
-
11.23.1 NeoStem Oncology Company Details
-
11.23.2 NeoStem Oncology Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 NeoStem Oncology Cancer Targeted Therapy Main Business and Markets Served
-
11.23.4 NeoStem Oncology Cancer Targeted Therapy Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Pfizer
-
11.24.1 Pfizer Company Details
-
11.24.2 Pfizer Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Pfizer Cancer Targeted Therapy Main Business and Markets Served
-
11.24.4 Pfizer Cancer Targeted Therapy Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 ImmunoCellular Therapeutics
-
11.25.1 ImmunoCellular Therapeutics Company Details
-
11.25.2 ImmunoCellular Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 ImmunoCellular Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
11.25.4 ImmunoCellular Therapeutics Cancer Targeted Therapy Product Portfolio
-
11.25.5 Recent Research and Development Strategies
12 Global Cancer Targeted Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Cancer Targeted Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tumor Antigens As Targets of Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Development of Antibodies for Clinical Purposes Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Complement Dependent Cytotoxicity (CDC) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Signal Transduction Changes Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Cancer Targeted Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Cancer Targeted Therapy Market Analysis and Outlook to 2028
-
13.1 Global Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Cancer Targeted Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Cancer Targeted Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Cancer Targeted Therapy
-
Figure of Cancer Targeted Therapy Picture
-
Table Global Cancer Targeted Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Cancer Targeted Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tumor Antigens As Targets of Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Development of Antibodies for Clinical Purposes Consumption and Growth Rate (2017-2022)
-
Figure Global Complement Dependent Cytotoxicity (CDC) Consumption and Growth Rate (2017-2022)
-
Figure Global Signal Transduction Changes Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Table North America Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure United States Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure Germany Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure China Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure Brazil Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Cancer Targeted Therapy Consumption by Country (2017-2022)
-
Figure Australia Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Cancer Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Table Genetech Company Details
-
Table Genetech Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genetech Cancer Targeted Therapy Main Business and Markets Served
-
Table Genetech Cancer Targeted Therapy Product Portfolio
-
Table ImmunoGen Company Details
-
Table ImmunoGen Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoGen Cancer Targeted Therapy Main Business and Markets Served
-
Table ImmunoGen Cancer Targeted Therapy Product Portfolio
-
Table Dendreon Corporation Company Details
-
Table Dendreon Corporation Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dendreon Corporation Cancer Targeted Therapy Main Business and Markets Served
-
Table Dendreon Corporation Cancer Targeted Therapy Product Portfolio
-
Table Peregrine Pharmaceuticals Company Details
-
Table Peregrine Pharmaceuticals Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Peregrine Pharmaceuticals Cancer Targeted Therapy Main Business and Markets Served
-
Table Peregrine Pharmaceuticals Cancer Targeted Therapy Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cancer Targeted Therapy Main Business and Markets Served
-
Table Sanofi Cancer Targeted Therapy Product Portfolio
-
Table Advaxis Company Details
-
Table Advaxis Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advaxis Cancer Targeted Therapy Main Business and Markets Served
-
Table Advaxis Cancer Targeted Therapy Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cancer Targeted Therapy Main Business and Markets Served
-
Table Johnson & Johnson Cancer Targeted Therapy Product Portfolio
-
Table GalaxoSmithKline Company Details
-
Table GalaxoSmithKline Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GalaxoSmithKline Cancer Targeted Therapy Main Business and Markets Served
-
Table GalaxoSmithKline Cancer Targeted Therapy Product Portfolio
-
Table Eli Lily Company Details
-
Table Eli Lily Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lily Cancer Targeted Therapy Main Business and Markets Served
-
Table Eli Lily Cancer Targeted Therapy Product Portfolio
-
Table NewLink Genetics Company Details
-
Table NewLink Genetics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NewLink Genetics Cancer Targeted Therapy Main Business and Markets Served
-
Table NewLink Genetics Cancer Targeted Therapy Product Portfolio
-
Table Bind Therapeutics Company Details
-
Table Bind Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bind Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
Table Bind Therapeutics Cancer Targeted Therapy Product Portfolio
-
Table Celldex Therapeutics Company Details
-
Table Celldex Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celldex Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
Table Celldex Therapeutics Cancer Targeted Therapy Product Portfolio
-
Table Inovio Pharmaceuticals Company Details
-
Table Inovio Pharmaceuticals Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Inovio Pharmaceuticals Cancer Targeted Therapy Main Business and Markets Served
-
Table Inovio Pharmaceuticals Cancer Targeted Therapy Product Portfolio
-
Table Bristol Mayer Squibb Company Details
-
Table Bristol Mayer Squibb Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Mayer Squibb Cancer Targeted Therapy Main Business and Markets Served
-
Table Bristol Mayer Squibb Cancer Targeted Therapy Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Targeted Therapy Main Business and Markets Served
-
Table Novartis Cancer Targeted Therapy Product Portfolio
-
Table Galena Biopharma Company Details
-
Table Galena Biopharma Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galena Biopharma Cancer Targeted Therapy Main Business and Markets Served
-
Table Galena Biopharma Cancer Targeted Therapy Product Portfolio
-
Table Merck Company Details
-
Table Merck Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Targeted Therapy Main Business and Markets Served
-
Table Merck Cancer Targeted Therapy Product Portfolio
-
Table Roche Company Details
-
Table Roche Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Cancer Targeted Therapy Main Business and Markets Served
-
Table Roche Cancer Targeted Therapy Product Portfolio
-
Table Seattle Genetics Company Details
-
Table Seattle Genetics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Cancer Targeted Therapy Main Business and Markets Served
-
Table Seattle Genetics Cancer Targeted Therapy Product Portfolio
-
Table Northwest Biotherapeutics Company Details
-
Table Northwest Biotherapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Northwest Biotherapeutics Cancer Targeted Therapy Main Business and Markets Served
-
Table Northwest Biotherapeutics Cancer Targeted Therapy Product Portfolio
-
Table Teva Company Details
-
Table Teva Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Cancer Targeted Therapy Main Business and Markets Served
-
Table Teva Cancer Targeted Therapy Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Cancer Targeted Therapy Main Business and Markets Served
-
Table Boehringer Ingelheim Cancer Targeted Therapy Product Portfolio
-
Table NeoStem Oncology Company Details
-
Table NeoStem Oncology Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NeoStem Oncology Cancer Targeted Therapy Main Business and Markets Served
-
Table NeoStem Oncology Cancer Targeted Therapy Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cancer Targeted Therapy Main Business and Markets Served
-
Table Pfizer Cancer Targeted Therapy Product Portfolio
-
Table ImmunoCellular Therapeutics Company Details
-
Table ImmunoCellular Therapeutics Cancer Targeted Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoCellular Therapeutics Cancer Targeted Therapy Main Business and Markets Served
-
Table ImmunoCellular Therapeutics Cancer Targeted Therapy Product Portfolio
-
Figure Global Tumor Antigens As Targets of Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Development of Antibodies for Clinical Purposes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Complement Dependent Cytotoxicity (CDC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Signal Transduction Changes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Cancer Targeted Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Cancer Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
